Postdoctoral Position in AI-Driven Drug Design
University of Basel
Artificial intelligence is rapidly transforming molecular design and drug discovery. However, the identification of successful drug candidates requires more than generating molecules with high predicted affinity: selectivity, physicochemical properties, potential adverse effects, synthetic accessibility, and experimental feedback must be considered simultaneously. Our research in the Computational Pharmacy group at the University of Basel focuses on developing next-generation AI approaches for drug design by combining state-of-the-art machine learning with physicochemical knowledge and…
